Research and experimental development on natural sciences and engineering
IMMUNOR AS
Operating profit
NOK −1.3m
Equity
NOK −106,000
Incorporated
2014
Share capital
NOK 138,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating costs | 1.3m | |
| Operating profit (EBIT) | −1.3m | |
| Net financial items | −66k | |
| Profit for the year | −1.4m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 404k | |
| of which current assets | 367k | |
| Equity | −106k | |
| Total liabilities | 510k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.